Partnerships in Global Health
In partnership with the Bill & Melinda Gates Foundation and Malaria Vaccines Initiative, The Walter and Eliza Hall Institute of Medical Research is developing strategies to eradicate Malaria.
- The Global Health Program of the Bill & Melinda Gates Foundation granted the Institute $ 2.9 million to enable preclinical malaria vaccine target validation in collaboration with Ehime University in Japan.
- A genetically attenuated malaria parasite vaccine will shortly enter phase 1 clinical trials. This work is being done in collaboration with the Seattle Biomedical Research Institute.
- A follow-up genetically attenuated vaccine is being developed at the Institute with support from a Grand Challenges Explorations grant.
- Following a successful bid to the Commonwealth Government’s Australia-India Strategic Research Fund, a collaboration with the International Centre for Genetic Engineering and Biotechnology, New Delhi, India is underway to develop blood-stage vaccines for malaria.
- A prototype malaria vaccine which targets a newly identified dendritic cell molecule is being tested to determine whether a strong antibody response can be induced without the use of adjuvants.
- A vaccine to reduce inflammation associated with cerebral malaria is in pre-clinical development.